BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37569793)

  • 21. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Birt-Hogg-Dubé syndrome in a patient with localized fibrofolliculomas and a novel mutation in the FLCN gene.
    Alonso-González J; Rodríguez-Pazos L; Fernández-Redondo V; Vega-Gliemmo A; Toribio J
    Int J Dermatol; 2011 Aug; 50(8):968-71. PubMed ID: 21781069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population.
    Savatt JM; Shimelis H; Moreno-De-Luca A; Strande NT; Oetjens MT; Ledbetter DH; Martin CL; Myers SM; Finucane BM
    Genet Med; 2022 Sep; 24(9):1857-1866. PubMed ID: 35639097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
    Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome.
    Torricelli E; Occhipinti M; Cavigli E; Tancredi G; Rosi E; Rossi C; Bonaguro M; Candita L; Papi L; Novelli L; Bezzi M; Bargagli E; Voltolini L; Pistolesi M
    Respiration; 2019; 98(2):125-132. PubMed ID: 31266032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
    Wu J; Lu J; Wu CL; Lu M
    Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
    Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
    Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic characteristics of Chinese patients with BHD syndrome and functional analysis of FLCN variants.
    Liu K; Xu W; Tian X; Xiao M; Zhao X; Zhang Q; Qu T; Song J; Liu Y; Xu KF; Zhang X
    Orphanet J Rare Dis; 2019 Oct; 14(1):223. PubMed ID: 31615547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
    Bruinsma FJ; Dowty JG; Win AK; Goddard LC; Agrawal P; Attina' D; Bissada N; De Luise M; Eisen DB; Furuya M; Gasparre G; Genuardi M; Gerdes AM; Hansen TVO; Houweling AC; Johannesma PC; Lencastre A; Lim D; Lindor NM; Luzzi V; Lynch M; Maffé A; Menko FH; Michels G; Pulido JS; Ryu JH; Sattler EC; Steinlein OK; Tomassetti S; Tucker K; Turchetti D; van de Beek I; van Riel L; van Steensel M; Zenone T; Zompatori M; Walsh J; Bondavalli D; Maher ER; Winship IM;
    J Med Genet; 2023 Apr; 60(4):317-326. PubMed ID: 36849229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Kawakami F; Moritani S; Ota S; Hora M; Michal M; Hes O; Nakatani Y
    Pol J Pathol; 2014 Jun; 65(2):93-9. PubMed ID: 25119168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening.
    Vocke CD; Fleming LR; Piskorski AM; Amin A; Phornphutkul C; de la Monte S; Vilboux T; Duncan F; Pellegrino J; Braddock B; Middelton LA; Schmidt LS; Merino MJ; Cowen EW; Introne WJ; Linehan WM; Smith ACM
    Am J Med Genet A; 2023 Feb; 191(2):490-497. PubMed ID: 36513625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
    Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
    J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed diagnosis of Birt-Hogg-Dubé syndrome due to marked intrafamilial clinical variability: a case report.
    Sattler EC; Steinlein OK
    BMC Med Genet; 2018 Mar; 19(1):45. PubMed ID: 29548312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
    Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
    BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility.
    Preston RS; Philp A; Claessens T; Gijezen L; Dydensborg AB; Dunlop EA; Harper KT; Brinkhuizen T; Menko FH; Davies DM; Land SC; Pause A; Baar K; van Steensel MA; Tee AR
    Oncogene; 2011 Mar; 30(10):1159-73. PubMed ID: 21057536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.